OVARIAN CANCER MANIFESTED BY MESENTERIC AND HEPATIC VENOUS THROMBOSIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper describes a case of nonspecific manifestation of ovarian cancer, which reflects the typical complexities of a clinical search and the possible variants of increasing the informative value of studies to make an accurate diagnosis.

Full Text

Restricted Access

About the authors

Yu. Magdebura

S.P. Botkin City Clinical Hospital

A. Solopova

I.M. Sechenov First Moscow State Medical University

Email: dr.solopova@mail.ru
Candidate of Medical Sciences

References

  1. Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой / М.: МНИОИ им. П.А. Герцена, 2016.
  2. Prat J. Staging classification for cancer of the ovary, fallopian tube and peritoneum // Intern. J. Gynecol. Obstet. - 2014; 124 (1): 1-5.
  3. Siegel R., Ma J., Zou Z. et al. Cancer statistics, 2014 / CA: A Cancer Journal for Clinicians, 2014; 64.
  4. SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda. Avaible online at http://seer.cancer.gov/statfacts/html/ovary.html
  5. American Cancer Society. Cancer Facts & Figures 2016 / Atlanta: American Cancer Society, 2016.
  6. Mohaghegh P., Rockall A. Imaging Strategy for Early Ovarian Cancer: Characterization of Adnexal Masses with Conventional and Advanced Imaging Techniques // Radiographics. - 2012; 32 (6): doi: 10.1148/326125520.
  7. Бахтиозин Р.Ф., Сафиуллин Р.Р. Диффузионно-взвешенное изображение всего тела в диагностике онкологических заболеваний // Кубанский научный медицинский вестник. - 2010; 6: 16-20.
  8. Falanga A. Mechanism of hypercoagulation in malignancy and during chemotherapy // Haemostasis. - 1998; 28 (3): 50-60.
  9. Воробьев А.В., Макацария А.Д. Тромбофилия, тромбозы и антитромботическая терапия у онкологических больных // Акушерство, гинекология и репродукция. - 2014; 2: 139-48.
  10. Zhao T., Hu W. CA125 and HE4: Measurement Tools for Ovarian Cancer // Gynecol. Obstet. Invest. - 2016; doi: 10.1159/000442288.
  11. Anton C., Carvalho F., Oliveira E. et al. A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses // Clinics. - 2012; 67: 437-41. doi: 10.6061/clinics/2012(05)06.
  12. Harris R., Javitt M., Glanc Ph. et al. Clinically Suspected Adnexal Mass / ACR Appropriateness Criteria®, 2012.
  13. Forstner R. et al. ESUR guidelines: ovarian cancer staging and follow-up // Eur. Radiol. - 2010; 20: 2773-3780.
  14. Kaijser J., Bourne T., Valentin L. et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies // Ultrasound Obstet. Gynecol. - 2013; 41: 9-20.
  15. Spencer J. et al. ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach // Eur. Radiology. - 2010; 20: 25-35. doi: 10.1007/s00330-009-1584-2.
  16. Adusumilli S., Hussain H., Caoili E. et al. MRI of sonographically indeterminate adnexal masses // AJR Am. J. Roentgenol. - 2006; 187: 732-40.
  17. Sohaib S., Mills T., Sahdev A. et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses // Clin. Radiol. - 2005; 60: 340-8.
  18. Солопова А.Е., Чащин А.А., Солопова А.Г. и др. Современные взгляды на патогенез и возможности диагностики эпителиального рака яичников // Акушерство, гинекология и репродукция. - 2016; 10 (1): 75-83.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies